Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant

Journal of General Virology

Volumn 85, Issue 1, 2004, Pages 131-135

  Boname, Jessica M ^a   Coleman, Heather M ^a   May, Janet S ^a   Stevenson, Philip G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES VACCINE; LIVE VACCINE; TRANSACTIVATOR PROTEIN; VIRUS ANTIGEN; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SYNTHESIS; HERPES VIRUS; HERPES VIRUS INFECTION; IMMUNOGENICITY; INFECTION PREVENTION; LUNG; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SPLEEN; TRANSCRIPTION REGULATION; VIRUS IMMUNITY; VIRUS LATENCY; VIRUS MUTANT; VIRUS VIRULENCE; WILD TYPE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; DNA, VIRAL; GAMMAHERPESVIRINAE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; IMMUNITY, CELLULAR; LUNG; MICE; MICE, INBRED C57BL; MUTATION; SPLEEN; VACCINATION; VIRAL VACCINES; VIRUS LATENCY;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; MURINAE; MURINE HEPATITIS VIRUS;

EID: 1642503724     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19592-0     Document Type: Article

References (27)

1. Arico, E., Robertson, K., Allen, D., Ferrantini, M., Belardelli, F. & Nash, A. A. (2002). Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon. J Interferon Cytokine Res 22, 1081-1088.
2. Asano, Y. & Takahashi, M. (1977). Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children. Pediatrics 60, 810-814.
3. Binne, U. K., Amon, W. & Farrell, P. J. (2002). Promoter sequences required for reactivation of Epstein-Barr virus from latency. J Virol 76, 10282-10289.
4. Blasdell, K., McCracken, C., Morris, A., Nash, A. A., Begon, M., Bennett, M. & Stewart, J. P. (2003). The wood mouse is a natural host for Murid herpesvirus 4. J Gen Virol 84, 111-113.
5. Brooks, J. M., Croom-Carter, D. S., Leese, A. M., Tierney, R. J., Habeshaw, G. & Rickinson, A. B. (2000). Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. J Virol 74, 1801-1809.
6. Christensen, J. P. & Doherty, P. C. (1999). Quantitative analysis of the acute and long-term CD4(+) T-cell response to a persistent gammaherpesvirus. J Virol 73, 4279-4283.
7. Coleman, H. M., de Lima, B., Morton, V. & Stevenson, P. G. (2003). Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol 77, 2410-2417.
8. Doherty, P. C., Tripp, R. A., Hamilton-Easton, A. M., Cardin, R. D., Woodland, D. L. & Blackman, M. A. (1997). Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr Opin Immunol 9, 477-483.
9. Epstein, M. A., Morgan, A. J., Finerty, S., Randle, B. J. & Kirkwood, J. K. (1985). Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318, 287-289.
10. Liu, L., Usherwood, E. J., Blackman, M. A. & Woodland, D. L. (1999). T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J Virol 73, 9849-9857.
11. May, J. S., Coleman, H. M., Smillie, B., Efstathiou, S. & Stevenson, P. G. (2004). Forced lyric replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol 85, 137-146.
12. Sitki-Green, D., Covington, M. & Raab-Traub, N. (2003). Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 77, 1840-1847.
13. Stevenson, P. G. & Doherty, P. C. (1999). Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol 73, 1075-1079.
14. Stevenson, P. G., Belz, G. T., Castrucci, M. R., Altman, J. D. & Doherty, P. C. (1999a). A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A 96, 9281-9286.
15. Stevenson, P. G., Cardin, R. D., Christensen, J. P. & Doherty, P. C. (1999b). Immunological control of a murine gammaherpesvirus independent of CD8 + T cells. J Gen Virol 80, 477-483.
16. Stevenson, P. G., Belz, G. T., Altman, J. D. & Doherty, P. C. (1999c). Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma- herpesvirus infection. Eur J Immunol 29, 1059-1067.
17. Stevenson, P. G., Boname, J. M., de Lima, B. & Efstathiou, S. (2002a). A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection. Microbes Infect 4, 1177-1182.
18. Stevenson, P. G., May, J. S., Smith, X. G., Marques, S., Adler, H., Koszinowski, U. H., Simas, J. P. & Efstathiou, S. (2002b). K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3, 733-740.
19. Stewart, J. P., Janjua, N. J., Pepper, S. D., Bennion, G., Mackett, M., Allen, T., Nash, A. A. & Arrand, J. R. (1996). Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70, 3528-3535.
20. Stewart, J. P., Micali, N., Usherwood, E. J., Bonina, L. & Nash, A. A. (1999). Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gammaherpesvirus vaccination. Vaccine 17, 152-157.
21. Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F. & Miller, G. (1998). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95, 10866-10871.
22. Sunil-Chandra, N. P., Arno, J., Fazakerley, J. & Nash, A. A. (1994). Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am J Pathol 145, 818-826.
23. Tibbetts, S. A., McClellan, J. S., Gangappa, S., Speck, S. H. & Virgin, H. W. (2003). Effective vaccination against long-term gammaherpesvirus latency. J Virol 77, 2522-2529.
24. Usherwood, E. J., Ward, K. A., Blackman, M. A., Stewart, J. P. & Woodland, D. L. (2001). Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 75, 8283-8288.
25. Walling, D. M., Brown, A. L., Etienne, W., Keitel, W. A. & Ling, P. D. (2003). Multiple Epstein-Barr virus infections in healthy individuals. J Virol 77, 6546-6550.
26. Wills, M. R., Carmichael, A. J. & Sissons, J. G. (2002). Vaccines against persistent DNA virus infections. Br Med Bull 62, 125-138.
27. Wu, T. T., Usherwood, E. J., Stewart, J. P., Nash, A. A. & Sun, R. (2000). Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol 74, 3659-3667.